Affiliated Hospital To Academy Of Military Medical Sciences
Clinical trials sponsored by Affiliated Hospital To Academy Of Military Medical Sciences, explained in plain language.
-
Double-barreled CAR-T takes aim at hard-to-treat blood cancers
Disease control Not yet recruitingThis early-phase study tests a new type of immunotherapy called CAR19-BCMA CAR-T for people with certain blood cancers (plasma cell neoplasms, lymphomas, or leukemias) that have relapsed or stopped responding to at least three prior treatments. The therapy uses a patient's own im…
Phase: EARLY_PHASE1 • Sponsor: Affiliated Hospital to Academy of Military Medical Sciences • Aim: Disease control
Last updated May 26, 2026 10:17 UTC
-
Double-barreled CAR-T takes aim at hard-to-treat blood cancer
Disease control Not yet recruitingThis early-phase study tests a new cell therapy that targets two markers (BCMA and CD70) on high-risk plasma cell cancers, including multiple myeloma. About 20 participants will receive the treatment to see if it is safe and how well it works. The goal is to control the disease, …
Phase: EARLY_PHASE1 • Sponsor: Affiliated Hospital to Academy of Military Medical Sciences • Aim: Disease control
Last updated May 26, 2026 10:07 UTC
-
New dual CAR-T therapy aims to tackle tough lymphoma
Disease control Not yet recruitingThis early-phase study tests a new type of CAR-T cell therapy that targets two proteins (CD19 and CD20) on lymphoma cells. It is designed for people with B-cell lymphoma that has come back or not responded to standard treatments. The main goals are to check safety and find the be…
Phase: EARLY_PHASE1 • Sponsor: Affiliated Hospital to Academy of Military Medical Sciences • Aim: Disease control
Last updated May 20, 2026 11:57 UTC